Navigation Links
Helix BioPharma reports Q2 2008 highlights, financial results
Date:3/10/2008

12 12 24 24

Interest income, net (181) (142) (285) (244)

Foreign exchange loss (153) (172) (45) (127)

--------------------------------------

2,287 2,763 4,784 4,902

Loss before income taxes (1,496) (1,871) (3,108) (3,184)

Income taxes 30 29 62 58

--------------------------------------

Loss for the period (1,526) (1,900) (3,170) (3,242)

--------------------------------------

--------------------------------------

-----------------------------------------------------------------------

Loss per share:

Basic (0.04) (0.05) (0.08) (0.09)

Diluted (0.04) (0.05) (0.08) (0.09)

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Consolidated Statements of Cash Flows

for the three and six month periods ended January 31, 2008 and 2007

(thousand $)

Three months Six months

ended January 31 ended January 31

2008 2007 2008 2007

--------------------------------------

Cash provided by (used in):

Loss for the period (1,526) (1,900) (3,170) (3,242)

Items not involving cash:

Amortization of capital assets 63 73 129 150

Amortization of intangibles 3
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
..., Contributed by James V. Anderson and Char... of Food and Agricultural Sciences, , ...lin Heavy Chain Binding Proteins, also known as GR...-luminal proteins and members of the , HS...ort and folding process , of proteins inv...
..., Contributed by Alan T. Bakalinsky Departm...gon State University, Corvallis, OR 97331-6602, ...files of wine strains of Saccharomyces cerevisiae ...boratory karyotype. Qualitative analysis , ...the wine strains are aneuploid , and two ...
... , Marie Nguyen and William Strong, Bi...e, Hercules, CA 94547 USA , , I...yacrylamide gel electrophoresis (SDS-PAGE) , ...in separation. However, , this traditiona...and several , hours to complete. New micr...
... , Introduction , Amplific... (PCR) is a , highly sensitive method cap... just a single molecule. 1 Because of the ... carry-over product from previous reactions can re... Carry-over contamination can be avoided by using ...
Other Biology Technology:A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 2A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 3A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 4A Rapid Method for the Purification of Analytical Grade Proteins From Plants Using Preparative SDS-PAGE and Preparative IEF 5Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 2Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 3Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 4Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 5Electrophoretic Karyotypes of Wine Strains of Saccharomyces cerevisiae 6Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 2Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 3Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 4Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 5Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 6Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 7Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 8Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 9Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 10Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 11Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 12Performance Comparison of the Experion Automated Electrophoresis System and a Competing Automated System for Protein Analysis, Rev A 13Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 2Inactivation of Contaminating Templates in PCR Using High Intensity Ultraviolet Light 3
(Date:7/24/2008)...ne researchers have found a molecular link between...lism. The discovery reveals new possibilities for ...ed diseases. , Paolo Sassone-Corsi, Distinguishe...leagues have identified that an essential protein ...hythms, works in balance with another protein call...
(Date:7/24/2008)...cture Proteins (NSP), a new family of genes discov...ncer Research and Molecular Medicine in Temple Uni... be involved in apoptosis or programmed cell death...li Sang, then a doctoral student at the University...n University and the Cardeza Foundation, and Anton...
(Date:7/24/2008)...e typhoon in Taiwan buries as much carbon in the o...r rains in that country all year long combined. ,...study published in a recent issue of the journal ...ne the chemistry of stream water and sediments tha... happening at full force -- will help scientists d...
(Date:7/23/2008)...08 One of the reasons people on low-carbohydrate ...take of fructose, a type of sugar that can be made...at UT Southwestern Medical Center. , Dr. Eliza...ion and lead author of a study appearing in a curr...team,s findings suggest that the right type of car...
Breaking Biology News(10 mins):Circadian rhythm-metabolism link discovered 2Novel structure proteins could play a role in apoptosis 2Study: Typhoons bury tons of carbon in the oceans 2Study: Typhoons bury tons of carbon in the oceans 3Study: Typhoons bury tons of carbon in the oceans 4Limiting fructose may boost weight loss, UT Southwestern researcher reports 2Limiting fructose may boost weight loss, UT Southwestern researcher reports 3Israeli Scientists Recipients of 2008 International Adult Stem Cell Award 5654 1Israeli Scientists Recipients of 2008 International Adult Stem Cell Award 5654 2New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 1New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 2New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 3New Eloxatin 28R 29 28oxaliplatin injection 29 Prescribing Information in the U S Includes Six Year Overall Survival Data 2198 4Key to Angelina like cheeks 3F Add volume to deep fat compartment 20353 1Key to Angelina like cheeks 3F Add volume to deep fat compartment 20353 2C sections a critical factor in preterm birth increase 20351 1C sections a critical factor in preterm birth increase 20351 2
...University of Pittsburgh Professor of Anthropology...fessor of Biochemistry Bruno Maresca, published Ja... emerging understanding of cell structure lends st...iginally explained in his seminal work, Sudden Ori... (John Wiley & Sons, 2000). , In that book, Sc...
...ree grows widely throughout the country and is kno...mes called "gumballs." Now, this spiny fruit may b...make a lifesaving drug against bird flu ?a drug th...hers say. , Chemists have found that the seeds of ...shikimic acid, the starting material used to produ...
...aths to new therapeutic drugs, as well as a wide a...ted through, of all things, intelligent design. A...tional Laboratory (Berkeley Lab) and the Universit...ique in which the evolution of an important class ..., "We,ve taken enzymes that are promiscuous, meani...
...on in the world’s oceans, primarily caused by agri...velopment of far more male fish than female, there...ding to a study published today on the Web site of...ntal Science & Technology . The study is sched...rnal. , The finding, by Rudolf Wu, Ph.D., and coll...
Other Biology News:Pitt professor's theory of evolution gets boost from cell research 2Pitt professor's theory of evolution gets boost from cell research 3Sweetgum tree could help lessen shortage of bird flu drug 2Intelligently designed molecular evolution 2Intelligently designed molecular evolution 3Ocean 'dead zones' trigger sex changes in fish, posing extinction threat 2
Cytofix/Cytoperm Kit 250 Tests
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:
Anti-MAGE-D2/NRAGE-Like 2b GenBank Accession Number : NM_201222 Immunogen : peptide (C-QSQENQDTRPKVKAKK), corresponding to amino acids 161-176 of human MAGE-D2/NRAGE-Like 2b Formulation: antiserum
Request Info
Biology Products: